Fourrier A - Search Results

1

Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study.

Nègre-Pagès L, Grandjean H, Lapeyre-Mestre M, Montastruc JL, Fourrier A, Lépine JP, Rascol O; DoPaMiP Study Group. Nègre-Pagès L, et al. Among authors: fourrier a. Mov Disord. 2010 Jan 30;25(2):157-66. doi: 10.1002/mds.22760. Mov Disord. 2010. PMID: 19950403

2

Patterns of neuroleptic drug prescription: a national cross-sectional survey of a random sample of French psychiatrists.

Fourrier A, Gasquet I, Allicar MP, Bouhassira M, Lépine JP, Bégaud B. Fourrier A, et al. Br J Clin Pharmacol. 2000 Jan;49(1):80-6. doi: 10.1046/j.1365-2125.2000.00108.x. Br J Clin Pharmacol. 2000. PMID: 10606841 Free PMC article.

3

[Psychotropic drug use and mental psychiatric disorders in France; results of the general population ESEMeD/MHEDEA 2000 epidemiological study].

Gasquet I, Nègre-Pagès L, Fourrier A, Nachbaur G, El-Hasnaoui A, Kovess V, Lépine JP. Gasquet I, et al. Among authors: fourrier a. Encephale. 2005 Mar-Apr;31(2):195-206. doi: 10.1016/s0013-7006(05)82386-3. Encephale. 2005. PMID: 15959446 French.

4

Patterns and correlates of benzodiazepine use in the French general population.

Lagnaoui R, Depont F, Fourrier A, Abouelfath A, Bégaud B, Verdoux H, Moore N. Lagnaoui R, et al. Among authors: fourrier a. Eur J Clin Pharmacol. 2004 Sep;60(7):523-9. doi: 10.1007/s00228-004-0808-2. Eur J Clin Pharmacol. 2004. PMID: 15338086

5

Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study.

Depont F, Fourrier A, Merlière Y, Droz C, Amouretti M, Bégaud B, Bénichou J, Moride Y, Velo GP, Sturkenboom M, Blin P, Moore N; CADEUS Team. Depont F, et al. Among authors: fourrier a. Pharmacoepidemiol Drug Saf. 2007 Aug;16(8):891-900. doi: 10.1002/pds.1388. Pharmacoepidemiol Drug Saf. 2007. PMID: 17351983

6

Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use.

Fourrier A, Letenneur L, Dartigues JF, Moore N, Bégaud B. Fourrier A, et al. Eur J Clin Pharmacol. 2001 Aug;57(5):419-25. doi: 10.1007/s002280100326. Eur J Clin Pharmacol. 2001. PMID: 11599660

7

Incidence and predictors of drug-treated diabetes in elderly French subjects. The PAQUID Epidemiological Survey.

Bourdel-Marchasson I, Dubroca B, Letenneur L, Fourrier A, Richard-Harston S, Decamps A, Rainfray M, Emeriau JP, Dartigues JF. Bourdel-Marchasson I, et al. Among authors: fourrier a. Diabet Med. 2000 Sep;17(9):675-81. doi: 10.1046/j.1464-5491.2000.00362.x. Diabet Med. 2000. PMID: 11051288

8

A simple method to estimate sample sizes for safety equivalence studies using inverse sampling.

Moore N, Tubert-Bitter P, Fourrier A, Bégaud B. Moore N, et al. Among authors: fourrier a. J Clin Epidemiol. 2003 May;56(5):433-5. doi: 10.1016/s0895-4356(02)00608-x. J Clin Epidemiol. 2003. PMID: 12812816

9

Differences between clinical trials and postmarketing use.

Martin K, Bégaud B, Latry P, Miremont-Salamé G, Fourrier A, Moore N. Martin K, et al. Among authors: fourrier a. Br J Clin Pharmacol. 2004 Jan;57(1):86-92. doi: 10.1046/j.1365-2125.2003.01953.x. Br J Clin Pharmacol. 2004. PMID: 14678345 Free PMC article.

10

NSAID use profiles derived from reimbursement data in France.

Moore N, Diris H, Martin K, Viale R, Fourrier A, Moride Y, Bégaud B. Moore N, et al. Among authors: fourrier a. Therapie. 2004 Sep-Oct;59(5):541-6. doi: 10.2515/therapie:2004092. Therapie. 2004. PMID: 15648307

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters